Home  >  Products  >  NFE2L1 (nuclear factor (erythroid-derived 2)-like 1 ) Blocking Peptide (the C terminal of NFE2L1)(100ug)
NFE2L1 (nuclear factor (erythroid-derived 2)-like 1 ) Blocking Peptide (the C terminal of NFE2L1)(100ug)

NFE2L1 (nuclear factor (erythroid-derived 2)-like 1 ) Blocking Peptide (the C terminal of NFE2L1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-NFE2L1 Antibody (ARP31114_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP31114
Size: 100ug
Weight: 85kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: NFE2L1 activates erythroid-specific, globin gene expression.
Alternative names: FLJ00380; LCR-F1; NRF1; TCF11
See Full Product Listings >